Active Postmarketing Drug Surveillance for Multiple Adverse Events

Published Online:https://doi.org/10.1287/opre.2015.1435

References

  • Abbott R, Donahue R, MacMahon S, Reed D, Yano K (1987) Diabetes and the risk of stroke: The Honolulu heart program. J. Amer. Med. Assoc. 257(7):949–952.CrossrefGoogle Scholar
  • Barrett-Connor E, Khaw KT (1988) Diabetes mellitus: An independent risk factor for stroke? Amer. J. Epidemiol 128(1):116–123.CrossrefGoogle Scholar
  • Bate A, Lindquist M, Edwards I, Olsson S, Orre R, Lansner A, De Freitas R (1998) A Bayesian neural network method for adverse drug reaction signal generation. Eur. J. Clinical Pharmacology 54(4):315–321.CrossrefGoogle Scholar
  • Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, Greenland P, Van Horn L, Tracy RP, Lloyd-Jones DM (2012) Lifetime risks of cardiovascular disease. New England J. Medicine 366(4):321–329.CrossrefGoogle Scholar
  • Brewer T, Colditz G (1999) Postmarketing surveillance and adverse drug reactions. J. Amer. Medicine Assoc. 281(9):824–829.CrossrefGoogle Scholar
  • Brown J, Kulldorff M, Chan K, Davis R, Graham D, Pettus P, Andrade Set al. (2007) Early detection of adverse drug events within population-based health networks: Application of sequential testing methods. Pharmacoepidem Drug Safety 16(12):1275–1284.CrossrefGoogle Scholar
  • Cox DR (1972) Regression models and life-tables. J. Roy. Statist. Soc. Series B (Methodological) 34(2):187–220.CrossrefGoogle Scholar
  • Deyo R (2004) Gaps, tensions, and conflicts in the FDA approval process: Implications for clinical practice. J. Amer. Board Family Medicine 17(2):142–149.CrossrefGoogle Scholar
  • DuMouchel W (1999) Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Amer. Statistician 53(3):177–190.Google Scholar
  • Eick S, Massey W, Whitt W (1993) The physics of the Mt/G/∞ queue. Oper. Res. 41(4):731–742.LinkGoogle Scholar
  • Evans S, Waller P, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiology Drug Safety 10(6):483–486.CrossrefGoogle Scholar
  • FDA (2012) FDA’s Sentinel Initiative. Accessed April 10, 2012, http://www.fda.gov/Safety/FDAsSentinelInitiative/.Google Scholar
  • Fisher LD, Lin DY (1999) Time-dependent covariates in the Cox proportional-hazards regression model. Annual Rev. Public Health 20(1):145–157.CrossrefGoogle Scholar
  • Frasure-Smith N, Lespérance F, Talajic M (1993) Depression following myocardial infarction. J. Amer. Medicine Assoc. 270(15):1819–1825.CrossrefGoogle Scholar
  • Furberg C, Levin A, Gross P, Shapiro R, Strom B (2006) The FDA and drug safety: A proposal for sweeping changes. Arch. Intern. Medicine 166(18):1938–1942.CrossrefGoogle Scholar
  • Grant M, Boyd S (2011) CVX: Matlab software for disciplined convex programming, version 1.21, http://cvxr.com/cvx.Google Scholar
  • Haffner S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New England J. Medicine 339(4):229–234.CrossrefGoogle Scholar
  • Hauck DJ, Keats JB (1997) Robustness of the exponential sequential probability ratio test (SPRT) when Weibull distributed failures are transformed using a “known” shape parameter. Microelectronics Reliability 37(12):1835–1840.CrossrefGoogle Scholar
  • Jennison C, Turnbull BW (1999) Group Sequential Methods with Applications to Clinical Trials (Chapman and Hall/CRC, Boca Raton, FL).CrossrefGoogle Scholar
  • Kannel W, McGee D (1979) Diabetes and cardiovascular disease. J. Amer. Medicine Assoc. 241(19):2035.CrossrefGoogle Scholar
  • Klein N, Fireman B, Yih W, Lewis E, Kulldorff M, Ray P, Baxter R, Hambidge S, Nordin J, Naleway Aet al. (2010) Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 126(1):e1–e8.CrossrefGoogle Scholar
  • Kulldorff M, Davis R, Kolczak M, Lewis E, Lieu T, Platt R (2011) A maximized sequential probability ratio test for drug and vaccine safety surveillance. Sequential Anal. 30(1):58–78.CrossrefGoogle Scholar
  • Lai T (1991) Asymptotic optimality of generalized sequential likelihood ratio tests in some classical sequential testing procedures. Ghosh PKSBK, ed. Handbook of Sequential Analysis (Dekker, New York), 121–144.Google Scholar
  • Lai TL, Shih M-C (2004) Power, sample size and adaptation considerations in the design of group sequential clinical trials. Biometrika 91(3):507–528.CrossrefGoogle Scholar
  • Lieu T, Kulldorff M, Davis R, Lewis E, Weintraub E, Yih K, Yin R, Brown J, Platt Ret al. (2007) Real-time vaccine safety surveillance for the early detection of adverse events. Medicine Care 45(10):S89–S95.CrossrefGoogle Scholar
  • Luchsinger J, Tang M, Stern Y, Shea S, Mayeux R (2001) Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. Amer. J. Epidemiol. 154(7):635–641.CrossrefGoogle Scholar
  • Manson J, Colditz G, Stampfer M, Willett W, Krolewski A, Rosner B, Arky R, Speizer F, Hennekens C (1991) A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch. Intern. Medicine 151(6):1141–1147.CrossrefGoogle Scholar
  • Massey WA, Whitt W (1993) Networks of infinite-server queues with nonstationary Poisson input. Queueing Systems 13(1–3):183–250.CrossrefGoogle Scholar
  • McClellan M (2007) Drug safety reform at the FDA pendulum swing or systematic improvement? New England J. Medicine 356(17):1700–1702.CrossrefGoogle Scholar
  • Nelson J, Cook A, Yu O (2009) Evaluation of signal detection methods for use in prospective post licensure medical product safety surveillance. FDA Sentinel Initiative Safety Signal Identification contract. Report, Food and Drug Administration, Washington, DC.Google Scholar
  • Pandit PV, Gudaganavar NV (2010) On robustness of a sequential test for scale parameter of gamma and exponential distributions. Appl. Math. 1(4):274–278.CrossrefGoogle Scholar
  • Poor HV, Hadjiliadis O (2009) Quickest Detection (Cambridge University Press, New York).Google Scholar
  • Shaffer J (1995) Multiple hypothesis testing. Annu. Rev. Psychol 46(1): 561–584.CrossrefGoogle Scholar
  • Shih MC, Lai TL, Heyse JF, Chen J (2010) Sequential generalized likelihood ratio tests for vaccine safety evaluation. Statist. Medicine 29(26):2698–2708.CrossrefGoogle Scholar
  • Siegmund D (1985) Sequential Analysis: Tests and Confidence Intervals (Springer, New York).CrossrefGoogle Scholar
  • Toh K, Todd M, Tütüncü R (1999) SDPT3—A MATLAB software package for semidefinite programming, version 1.3. Optim. Method Software 11(1):545–581.CrossrefGoogle Scholar
  • Tütüncü R, Toh K, Todd M (2003) Solving semidefinite-quadratic-linear programs using SDPT3. Math. Program. 95(2):189–217.CrossrefGoogle Scholar
  • Vita AJ, Terry RB, Hubert HB, Fries JF (1998) Aging, health risks, and cumulative disability. New England J. Medicine 338(15):1035–1041.CrossrefGoogle Scholar
  • Wald A (1945) Sequential tests of statistical hypotheses. Ann. Math. Stat. 16(2):117–186.CrossrefGoogle Scholar
  • Wald A, Wolfowitz J (1948) Optimum character of the sequential probability ratio test. Ann. Math. Stat. 19(3):326–339.CrossrefGoogle Scholar
  • Wisniewski S, Rush A, Nierenberg A, Gaynes B, Warden D, Luther J, McGrath P, Lavori P, Thase M, Fava Met al. (2009) Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR* D report. Amer. J. Psychiatry 166(5):599.CrossrefGoogle Scholar
  • Yih W, Nordin J, Kulldorff M, Lewis E, Lieu T, Shi P, Weintraub E (2009) An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (TDAP) vaccine, using active surveillance for adverse events in the vaccine safety datalink. Vaccine 27(32):4257–4262.CrossrefGoogle Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.